Skip to content

Male breAsT cAncer preDisposition Factor

Male breAsT cAncer preDisposition Factor

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06219187
Acronym
MATADOR
Enrollment
93
Registered
2024-01-23
Start date
2024-02-08
Completion date
2025-02-06
Last updated
2025-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

Breast Cancer, PreDisposition factor

Brief summary

This is a non-interventional, prospective, single-center study designed to collect and describe environmental and psychosocial data from patients with a history of male breast cancer (MBC) referenced in the IUCT-O regional database. The study will be conducted on a population of 110 to 150 patients.

Interventions

To meet the study's objective, patients will be asked to complete a questionnaire characterizing their environmental and psychosocial context. The questionnaire is to be completed by the patients themselves, or by their trusted support person as recorded in their medical records (in the particular case of a deceased patient). It is estimated that the questionnaire will take around 30 minutes to complete. Data will also be collected from the medical records of included patients: * Demographics * Disease data

Sponsors

Ligue contre le cancer, France
CollaboratorOTHER
Institut Claudius Regaud
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Male patient with a personal history of breast cancer 2. Age ≥ 18 years 3. Patient who has had an oncogenetic consultation at IUCT-O and is registered in the IUCT-O oncogenetic database 4. Patient for whom no pathogenic variant has been detected on the HBOC panel (HBOC-) 5. Patient with no objection to participation in the trial (for deceased patients: trusted support person with no objection to participation).

Exclusion criteria

1\. Patient who has forfeited his/her freedom by administrative or legal award or who is under legal protection (curatorship and guardianship, protection of justice).

Design outcomes

Primary

MeasureTime frameDescription
The environmental data in the questionnaire will be described by the usual descriptive statistics.15 days for each patientA 75-question questionnaire will cover such aspects as the patient's living conditions, professional situation, qualifications or level of education, social environment, early life and family environment, general health and recent significant events. Quantitative data will be described by the median, minimum, maximum and number of missing data, and qualitative data by the numbers, percentages and number of missing data for each modality.
Psychosocial data from the questionnaire will be described using standard descriptive statistics.15 days for each patientA 75-question questionnaire will cover such aspects as the patient's living conditions, professional situation, qualifications or level of education, social environment, early life and family environment, general health and recent significant events. Quantitative data will be described by the median, minimum, maximum and number of missing data, and qualitative data by the numbers, percentages and number of missing data for each modality.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026